Charles River to Provide CDMO Services to FibroBiologics for 2025 DFU Therapy Trial

  • FibroBiologics and Charles River Laboratories have signed a master services agreement for the development and manufacturing of CYWC628, a fibroblast-based product for a 2025 clinical trial.
  • The technology transfer for CGMP manufacturing has been completed, with Charles River serving as the CDMO for the diabetic foot ulcer treatment.

FibroBiologics and Charles River Laboratories have entered a master services agreement to develop and manufacture FibroBiologics’ fibroblast-based therapeutic product, CYWC628. This product is set to be used in a diabetic foot ulcer (DFU) clinical trial scheduled to begin in 2025.

FibroBiologics is focused on developing treatments for chronic diseases using fibroblast cells, with over 160 patents supporting their work. The clinical trial for CYWC628 will test the product’s potential in wound healing, with diabetic foot ulcers being a primary focus.

The agreement follows the successful completion of a technology transfer from FibroBiologics to Charles River, including feasibility studies on the proprietary cell manufacturing processes. Under the terms of the agreement, Charles River will serve as the contract development and manufacturing organisation (CDMO), using its CGMP facilities to produce the drug product for the upcoming trial.

Charles River’s role in this project highlights its capabilities in cell and gene therapy CDMO services, which encompass the production of plasmid DNA, viral vectors, and cell therapies. The company’s global manufacturing and testing services aim to streamline supply chains for advanced therapies.

Pete O’Heeron, CEO of FibroBiologics, said: “The formalization of our working relationship with Charles River is a pivotal step as we advance toward a significant wound care clinical trial in 2025 with CYWC628.”

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

ELEARNING

Learn the essentials of successful biopharma outsourcing

New eLearning course distils 100+ expert interviews into 10 engaging modules.

tick Overview of outsourcing trends 
tick Expert insights and case studies 
tick Helpful resources and quizzes

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.